GGrantIndex
← Search

ANCILLARY STUDY OF THE ADOPTION AND SUSTAINABILITY OF ED-INITIATED BUPRENORPHINE (CTN-0079-A-1). DSC5 CONTRACT. 09/20/2019 - 02/28/2021. N01DA-19-2250.

$552,523N01FY2019DANIH

The Emmes Company, Llc, Rockville MD

Investigators

Paul Vanveldhuisencontact

Abstract

ANCILLARY STUDY OF THE ADOPTION AND SUSTAINABILITY OF ED-INITIATED BUPRENORPHINE (CTN-0079-A-1)

View original record on NIH RePORTER →
ANCILLARY STUDY OF THE ADOPTION AND SUSTAINABILITY OF ED-INITIATED BUPRENORPHINE (CTN-0079-A-1). DSC5 CONTRACT. 09/20/2019 - 02/28/2021. N01DA-19-2250. · GrantIndex